dipyridamole has been researched along with lfm a13 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Erbeck, D; Mahajan, S; Samuel, P; Tibbles, HE; Uckun, FM | 1 |
2 other study(ies) available for dipyridamole and lfm a13
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
In vivo toxicity and antithrombotic profile of the oral formulation of the antileukemic agent, LFM-A13-F.
Topics: Administration, Oral; Amides; Animals; Bleeding Time; Blood Cell Count; Blood Coagulation; Collagen; Dipyridamole; Female; Fibrinolytic Agents; Mice; Mice, Inbred BALB C; Nitriles; Platelet Aggregation Inhibitors; Thromboembolism | 2004 |